Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy.

Barbaro B, Vitale R, Leccisotti L, Vecchio FM, Santoro L, Valentini V, Coco C, Pacelli F, Crucitti A, Persiani R, Bonomo L.

Radiographics. 2010 May;30(3):699-716. doi: 10.1148/rg.303095085.

PMID:
20462989
2.

Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.

Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, Gava M, Fanti S, Mariani G, Muzzio PC, Rubello D.

Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1583-93.

PMID:
17503039
3.

Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy.

Barbaro B, Fiorucci C, Tebala C, Valentini V, Gambacorta MA, Vecchio FM, Rizzo G, Coco C, Crucitti A, Ratto C, Bonomo L.

Radiology. 2009 Mar;250(3):730-9. doi: 10.1148/radiol.2503080310.

PMID:
19244043
4.

Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall?

Dresen RC, Beets GL, Rutten HJ, Engelen SM, Lahaye MJ, Vliegen RF, de Bruïne AP, Kessels AG, Lammering G, Beets-Tan RG.

Radiology. 2009 Jul;252(1):71-80. doi: 10.1148/radiol.2521081200.

PMID:
19403847
5.

Restaging of Rectal Cancer with MR Imaging after Concurrent Chemotherapy and Radiation Therapy.

Kim DJ, Kim JH, Lim JS, Yu JS, Chung JJ, Kim MJ, Kim KW.

Radiographics. 2010 Mar;30(2):503-16. doi: 10.1148/rg.302095046. Review.

PMID:
20228331
6.

Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy.

Kim SH, Lee JM, Hong SH, Kim GH, Lee JY, Han JK, Choi BI.

Radiology. 2009 Oct;253(1):116-25. doi: 10.1148/radiol.2532090027.

PMID:
19789256
7.

PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer.

Kristiansen C, Loft A, Berthelsen AK, Graff J, Lindebjerg J, Bisgaard C, Jakobsen A.

Dis Colon Rectum. 2008 Jan;51(1):21-5.

PMID:
17975715
8.

Invited commentary.

Tudorica A, Thomas CR Jr, Huang W.

Radiographics. 2010 May;30(3):716-9; discussion 719-20. No abstract available.

PMID:
20480547
9.

Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging.

Curvo-Semedo L, Lambregts DM, Maas M, Thywissen T, Mehsen RT, Lammering G, Beets GL, Caseiro-Alves F, Beets-Tan RG.

Radiology. 2011 Sep;260(3):734-43. doi: 10.1148/radiol.11102467.

PMID:
21673229
10.

Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?

Lahaye MJ, Beets GL, Engelen SM, Kessels AG, de Bruïne AP, Kwee HW, van Engelshoven JM, van de Velde CJ, Beets-Tan RG.

Radiology. 2009 Jul;252(1):81-91. doi: 10.1148/radiol.2521081364.

PMID:
19403848
11.

Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy.

Monguzzi L, Ippolito D, Bernasconi DP, Trattenero C, Galimberti S, Sironi S.

Eur J Radiol. 2013 Feb;82(2):234-40. doi: 10.1016/j.ejrad.2012.09.027.

PMID:
23122748
12.

Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT.

Ippolito D, Monguzzi L, Guerra L, Deponti E, Gardani G, Messa C, Sironi S.

Abdom Imaging. 2012 Dec;37(6):1032-40. doi: 10.1007/s00261-011-9839-1.

PMID:
22270580
13.

Patterns and signal intensity characteristics of pelvic recurrence of rectal cancer at MR imaging.

Sinaei M, Swallow C, Milot L, Moghaddam PA, Smith A, Atri M.

Radiographics. 2013 Sep-Oct;33(5):E171-87. doi: 10.1148/rg.335115170.

PMID:
24025941
14.
15.

Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation.

Intven M, Reerink O, Philippens ME.

J Magn Reson Imaging. 2015 Jun;41(6):1646-53. doi: 10.1002/jmri.24718.

PMID:
25124320
16.

Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy.

Allen SD, Padhani AR, Dzik-Jurasz AS, Glynne-Jones R.

AJR Am J Roentgenol. 2007 Feb;188(2):442-51.

PMID:
17242254
17.

Multimodal imaging evaluation in staging of rectal cancer.

Heo SH, Kim JW, Shin SS, Jeong YY, Kang HK.

World J Gastroenterol. 2014 Apr 21;20(15):4244-55. doi: 10.3748/wjg.v20.i15.4244. Review.

18.

Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.

Min BS, Choi YJ, Pyo HR, Kim H, Seong J, Chung HC, Rha SY, Kim NK.

Arch Surg. 2008 Nov;143(11):1091-7; discussion 1097. doi: 10.1001/archsurg.143.11.1091.

PMID:
19015468
19.

Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.

Shanmugan S, Arrangoiz R, Nitzkorski JR, Yu JQ, Li T, Cooper H, Konski A, Farma JM, Sigurdson ER.

Ann Surg Oncol. 2012 Jul;19(7):2178-85. doi: 10.1245/s10434-012-2248-z.

PMID:
22395978
20.
Items per page

Supplemental Content

Support Center